• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, November 12, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

EssilorLuxottica locked in leadership dispute, arbitration requested

by Staff Writer
March 4, 2019
in International
Reading Time: 2 mins read
A A
Share on FacebookShare on Twitter

Under the agreent signed by Essilor and Luxottica ahead of their euro 54 billion (AU$85.1 b) merger completed last year, both sides agreed that until 2021 they would share equal weight in the combined company’s leadership. However, both factions are now accusing the other of violating that agreent.As reported by the Financial Times, the disagreent surrounds the appointment of a new managing director for the merged group. Mr Hubert Sagnières, executive vice-chairman of EssilorLuxottica and former head of Essilor, accused Mr Leonardo Del Vecchio, executive chairman of EssilorLuxottica and former boss of Luxottica, of attpting to orchestrate a takeover of the merged company by forcing his choice of managing director onto the group.Del Vecchio, who is also EssilorLuxottica’s largest shareholder, denies the accusation.Escalating the situation, Del Vecchio has hit back through his family holding company Delfin by lodging an arbitration request with the International Chamber of Commerce (ICC) in Paris. The request claims that a “stalate” amongst the company’s board of directors is threatening to halt the integration process.Del Vecchio claims that Sagnières has committed a number of violations of the agreent, including not undertaking the “duties of sincere cooperation and good faith” that were previously established.The arbitration request is seeking an “injunction to respect this agreent until its expiry”. While there is no set length for arbitration cases, Reuters reports that the ICC usually takes two years to rule on matters like these. Following that, the defeated party then has the option to appeal.A public war of words has now been dragging on between Sagnières and Del Vecchio for several months, with each issuing public statents accusing the other of making a grab for power.EssilorLuxotica had previously committed to appointing a CEO of the merged group by the end of 2020. In Novber 2018, Del Vecchio put forward Mr Francesco Milleri, CEO of Luxottica, for the position. A CEO is yet to be appointed.The merger between Italian frame maker Luxottica and French lens maker Essilor was completed in October last year when Delfin transferred its stake in Luxottixa to Essilor. In March 2019, the company released its first financial results as a joint entity and reported relatively strong results. Despite this, the company’s share price has since been dragged down by the ongoing leadership dispute and concerns for its future stability. More reading:EssilorLuxottica releases first financial resultsEssilor-Luxottica merger complete 

Related Posts

Essilor Stellest lens are now approved for the US market. Image: EssilorLuxottica.

Essilor Stellest lens for myopia control gains FDA approval

by Staff Writer
November 12, 2025

EssilorLuxottica has announced the US Food and Drug Administration (FDA) has granted market authorisation for its Essilor Stellest lens using...

The Optos Siverstone RGB offers nine modalities in one device. Image: Optos.

Optos unveils ‘most advanced’ Silverstone RGB retinal imager

by Staff Writer
October 29, 2025

Retinal imaging device manufacturer Optos has announced the launch of Silverstone RGB, which it says is the most advanced product...

Fred Hollows Foundation Pacific trachoma lead Dr Anasaini Cama working with children in Fiji. Image: Shea Flynn/RTI International.

Eye disease trachoma eliminated in Fiji

by Staff Writer
October 27, 2025

The Fred Hollows Foundation has welcomed the World Health Organisation’s (WHO) announcement that Fiji has eliminated the eye disease trachoma...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited